Lung Cancer News and Research

Latest Lung Cancer News and Research

Researchers identify new lung stem cell that helps repair large airways

Researchers at UCLA have identified a new stem cell that participates in the repair of the large airways of the lungs, which play a vital role in protecting the body from infectious agents and toxins in the environment.

28 Jun 2011

Flamel, Digna Biotech enter joint development agreement for multiple products

Flamel Technologies SA and Digna Biotech SL today announced that the two companies have entered into a joint development agreement for the pre-clinical and clinical development of multiple products.

27 Jun 2011

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $2 million in research grants to researchers at 12 institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers.

22 Jun 2011

Prostate cancer risk and prevention

According to U.S. researchers smoking increases the risk that men who develop prostate cancer will die from their disease. The longer the men smoked, the greater the risk, said Stacey Kenfield of the Harvard School of Public Health in Boston, whose study appears in the Journal of the American Medical Association. Prostate cancer is the second-leading cause of cancer death in men behind lung cancer

22 Jun 2011

TESARO secures $101M in Series B financing

TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $101 million in a Series B financing to advance and expand the Company's cancer product portfolio.

21 Jun 2011

Panacea Global announces name change

Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.

20 Jun 2011

IsoRay announces combination therapy study for prostate cancer

IsoRay Inc., announced today a new dual therapy study using Cesium-131 brachytherapy (internal radiation therapy) and external beam radiation. Multiple sites have now received Institutional Review Board (IRB) approval for this study which will examine the efficacy of combining intensity modulated radiation (IMRT) with Cesium-131 brachytherapy to treat intermediate and high risk early stage prostate cancer.

20 Jun 2011

GRACE, LUNGevity announce free webinar program to highlight lung cancer research

LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago.

20 Jun 2011

Cancer Statistics 2011 report finds progress has not benefitted all segments of the population equally

A steady reduction in overall cancer death rates translates to the avoidance of about 898,000 deaths from cancer between 1990 and 2007, according to the latest statistics from the American Cancer Society.

18 Jun 2011

Low levels of education, poverty and other social factors contribute to many U.S. deaths

How researchers classify and quantify causes of death across a population has evolved in recent decades. In addition to long-recognized physiological causes such as heart attack and cancer, the role of behavioral factors-including smoking, dietary patterns and inactivity-began to be quantified in the 1990s. More recent research has begun to look at the contribution of social factors to U.S. mortality.

18 Jun 2011

Adolescent obese males at risk of cancer later in life: Study

According to a new study, men who are obese as teenagers are at a greater risk of cancer. Researchers claim that the risk remains even among those who lose weight later in life.

17 Jun 2011

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.

17 Jun 2011

Study shows deprivation leads to cancer inequality in England

MORE than 2,600 deaths in England from some of the most common types of cancer could be avoided each year if all cancer patients had the same chance of survival as the most affluent section of society, a new piece of research suggests.

17 Jun 2011

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio.

16 Jun 2011

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Some lung-cancer patients at UT Southwestern Medical Center are responding well to potential new drug therapies targeting genetic mutations. Their participation in a national study is helping to forge new avenues to attack the disease.

16 Jun 2011

High proportion of men with prostate cancer die from the disease

Up to half the number of men with prostate cancer who die do so as a direct result of the disease, rather than from other causes according to a new study presented at the National Cancer Intelligence Network conference in London.

15 Jun 2011

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

A type of virus known as the human reovirus possesses a remarkable trait: It can replicate inside and kill cancer cells that feature a common mutation, while leaving the body's normal cells alone.

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

Calcium-sensing receptor plays key role in lethal lung cancer complication

A protein previously thought not to exist in adult human lungs not only is present in normal and cancerous lung tissue, scientists have found, but it also has a major role in the development of a lethal complication of some lung cancers.

14 Jun 2011

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.

13 Jun 2011

Lung Cancer News and Research

Latest Lung Cancer News and Research

Researchers identify new lung stem cell that helps repair large airways

Flamel, Digna Biotech enter joint development agreement for multiple products

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

Prostate cancer risk and prevention

TESARO secures $101M in Series B financing

Panacea Global announces name change

IsoRay announces combination therapy study for prostate cancer

GRACE, LUNGevity announce free webinar program to highlight lung cancer research

Cancer Statistics 2011 report finds progress has not benefitted all segments of the population equally

Low levels of education, poverty and other social factors contribute to many U.S. deaths

Adolescent obese males at risk of cancer later in life: Study

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Study shows deprivation leads to cancer inequality in England

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

High proportion of men with prostate cancer die from the disease

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Calcium-sensing receptor plays key role in lethal lung cancer complication

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in